News & Press Releases
Filter by:
Why Masimo’s ‘Rare’ Move Pushes Apple Case Into Uncharted Territory
September 3, 2025
World Intellectual Property Review and Life Sciences Intellectual Property Review featured insights from Intellectual Property Division Chair Michael Renaud about Masimo’s decision to sue US Customs and Border Protection (CBP), the latest development in its legal battle with Apple. The article notes that it’s uncommon for a patent owner to sue CBP, which is backed by the US International Trade Commission (ITC), and that the results of this action may determine whether patent owners will still be able to rely on exclusion orders as enforcement tools in the future.
How Bankruptcy Law Caps Landlords' Rejected Lease Claims
August 28, 2025
Law360 published an article written by Associate Dormie Ko, Member Geoffrey Smith, and Of Counsel Timothy McKeon about how landlords often find themselves in disputes with debtor-tenants over damages resulting from companies using the bankruptcy process to reject unwanted leases. Given the significant increase in corporate bankruptcy filings in recent years, the authors outline what landlords should consider if their leases are rejected in bankruptcy.
As Congress Preps PAMA Reform Bill, Legislators Ask CMS to Delay Law's Implementation
August 28, 2025
Health Law Practice Chair and Health Care Enforcement Defense Practice Co-chair Karen Lovitch shared insights with 360Dx on recent letters sent by legislators to the Centers for Medicare and Medicaid Services (CMS), which request a delay in upcoming price cuts and reporting requirements related to the Protecting Access to Medicare Act (PAMA). Karen notes that the requests appear to fall within CMS's regulatory authority and align with past congressional actions aimed at maintaining stability in lab reimbursement policy.
Of Counsel Michelle Capezza recently shared insights with Fiduciary News in light of the recent "Democratizing Access to Alternative Assets for 401(K) Investors" executive order. The article emphasizes that fiduciaries must respond quickly and carefully to new regulations, protecting participants while adapting to a more complex retirement landscape.
SEC’s Pharmaceutical Insider Trading Case Yields Quick Deals
August 19, 2025
Bloomberg Law featured a statement from Member Jason P.W. Halperin in its coverage of a pharmaceutical insider trading case brought by the SEC. Jason and the Mintz team of Sean Prosser and Elizabeth Platonova represented Robert Yedid in reaching a resolution in which the client pled guilty and, along with the other defendants, entered into consent orders with the SEC.